{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:01:22Z","timestamp":1790816482204,"version":"4.1.0"},"reference-count":34,"publisher":"The Company of Biologists","issue":"2","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Neuromuscular disorders (NMDs) encompass a diverse group of genetic diseases characterized by loss of muscle functionality. Despite extensive efforts to develop therapies, no curative treatment exists for any of the NMDs. For multiple disorders, however, therapeutic strategies are currently being tested in clinical settings, and the first successful treatments have now entered clinical practice (e.g. spinraza for spinal muscular atrophy). Successful clinical translation depends on the quality and translatability of preclinical findings and on the predictive value of the experimental models used in their initial development. This Special Issue of Disease Models &amp; Mechanisms has a particular focus on translational research for NMDs. The collection includes original research focusing on advances in the development of novel in vitro and in vivo models, broader understanding of disease pathology and progression, and approaches to modify the disease course in these models. We also present a series of special articles and reviews that highlight our understanding of cellular mechanisms, biomarkers to tract disease pathology, the diversity of mouse models for NMDs, the importance of high-quality preclinical studies and data validation, and the pitfalls of successfully moving a potential therapeutic strategy to the clinic. In this Editorial, we summarize the highlights of these articles and place their findings in the broader context of the NMD research field.<\/jats:p>","DOI":"10.1242\/dmm.044370","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T17:25:19Z","timestamp":1582651519000},"source":"Crossref","is-referenced-by-count":12,"title":["Moving neuromuscular disorders research forward: from novel models to clinical studies"],"prefix":"10.1242","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0683-8897","authenticated-orcid":false,"given":"Maaike","family":"van Putten","sequence":"first","affiliation":[{"name":"Leiden University Medical Center 1 Department of Human Genetics , , Albinusdreef 2, 2333 ZA Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julija","family":"Hmeljak","sequence":"additional","affiliation":[{"name":"The Company of Biologists 2 Disease Models & Mechanisms , , Bidder Building, Station Road, Histon, Cambridge CB24 9LF , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center 1 Department of Human Genetics , , Albinusdreef 2, 2333 ZA Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Dowling","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children 3 Program for Genetics and Genome Biology , , Peter Gilgan Centre for Research and Learning (PGCRL), Bay St., 14th Floor, Toronto, ON M5G 0A4 , Canada"},{"name":"University of Toronto 4 Departments of Paediatrics and Molecular Genetics , , Toronto, ON M5G 1X8 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"2024061302412818000_DMM044370C1","doi-asserted-by":"publisher","first-page":"dmm041673","DOI":"10.1242\/dmm.041673","article-title":"The use of genetically humanized animal models for personalized medicine approaches","volume":"13","author":"Aartsma-Rus","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C2","doi-asserted-by":"publisher","first-page":"dmm041319","DOI":"10.1242\/dmm.041319","article-title":"Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration","volume":"13","author":"Ardan","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C3","doi-asserted-by":"publisher","first-page":"dmm041293","DOI":"10.1242\/dmm.041293","article-title":"Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease","volume":"13","author":"Baxa","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C4","doi-asserted-by":"publisher","first-page":"dmm038844","DOI":"10.1242\/dmm.038844","article-title":"Interactions among ryanodine receptor isotypes contribute to muscle fiber type development and function","volume":"13","author":"Chagovetz","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C5","doi-asserted-by":"publisher","first-page":"dmm041111","DOI":"10.1242\/dmm.041111","article-title":"A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy","volume":"13","author":"Cordero-Sanchez","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C6","doi-asserted-by":"publisher","first-page":"dmm041434","DOI":"10.1242\/dmm.041434","article-title":"Translational medicine in neuromuscular disorders: from academia to industry","volume":"13","author":"Cowling","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C7","doi-asserted-by":"publisher","first-page":"dmm037424","DOI":"10.1242\/dmm.037424","article-title":"Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis","volume":"12","author":"De Giorgio","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C8","doi-asserted-by":"publisher","first-page":"dmm.040832","DOI":"10.1242\/dmm.040832","article-title":"A gene-edited mouse model of Limb-Girdle muscular dystrophy 2C for testing exon skipping","volume":"13","author":"Demonbreun","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ajmg.a.38418","article-title":"Treating pediatric neuromuscular disorders: The future is now","volume":"176","author":"Dowling","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"2024061302412818000_DMM044370C10","doi-asserted-by":"publisher","first-page":"dmm037655","DOI":"10.1242\/dmm.037655","article-title":"CRISPR\/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene","volume":"12","author":"Egorova","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"2024061302412818000_DMM044370C12","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.041244","article-title":"Altered in vitro muscle differentiation in X-linked myopathy with excessive autophagy","volume":"13","author":"Fernandes","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C13","doi-asserted-by":"publisher","first-page":"dmm.041947","DOI":"10.1242\/dmm.041947","article-title":"Temporal evolution of the microbiome, immune system, and epigenome with disease progression in ALS mice","volume":"13","author":"Figueroa-Romero","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C14","doi-asserted-by":"publisher","first-page":"dmm041368","DOI":"10.1242\/dmm.041368","article-title":"Cored in the act: the use of models to understand core myopathies","volume":"12","author":"Fusto","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C15","doi-asserted-by":"publisher","first-page":"dmm032946","DOI":"10.1242\/dmm.032946","article-title":"Collagen VI in healthy and diseased nervous system","volume":"11","author":"Gregorio","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C16","doi-asserted-by":"publisher","first-page":"dmm043638","DOI":"10.1242\/dmm.043638","article-title":"Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress","volume":"13","author":"Grounds","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C17","doi-asserted-by":"publisher","first-page":"dmm029462","DOI":"10.1242\/dmm.029462","article-title":"Generating mouse models for biomedical research: technological advances","volume":"12","author":"Gurumurthy","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13023-015-0258-1","article-title":"The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development","volume":"10","author":"Heslop","year":"2015","journal-title":"Orphanet. J. Rare. Dis."},{"key":"2024061302412818000_DMM044370C19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ilar\/ilu011","article-title":"Pharmacologic management of duchenne muscular dystrophy: target identification and preclinical trials","volume":"55","author":"Kornegay","year":"2014","journal-title":"ILAR J."},{"key":"2024061302412818000_DMM044370C20","doi-asserted-by":"publisher","first-page":"dmm043018","DOI":"10.1242\/dmm.043018","article-title":"To dystrophin and beyond: an interview with Louis Kunkel","volume":"13","author":"Kunkel","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C21","doi-asserted-by":"publisher","first-page":"dmm039552","DOI":"10.1242\/dmm.039552","article-title":"C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells","volume":"12","author":"Lynch","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C22","doi-asserted-by":"publisher","first-page":"dmm041566","DOI":"10.1242\/dmm.041566","article-title":"At the heart of genetic disease: an interview with Elizabeth McNally","volume":"13","author":"McNally","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/MOP.0b013e328365ace5","article-title":"Muscular dystrophy: new challenges and review of the current clinical trials","volume":"25","author":"Mercuri","year":"2013","journal-title":"Curr. Opin. Pediatr"},{"key":"2024061302412818000_DMM044370C24","doi-asserted-by":"publisher","first-page":"dmm042192","DOI":"10.1242\/dmm.042192","article-title":"Skeletal muscle in health and disease","volume":"13","author":"Morgan","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C25","doi-asserted-by":"publisher","first-page":"dmm035931","DOI":"10.1242\/dmm.035931","article-title":"The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy","volume":"11","author":"Nickolls","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C26","doi-asserted-by":"publisher","first-page":"dmm042101","DOI":"10.1242\/dmm.042101","article-title":"Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes","volume":"13","author":"O'Brien","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C27","doi-asserted-by":"publisher","first-page":"dmm041541","DOI":"10.1242\/dmm.041541","article-title":"Modelling the pathogenesis of X-linked distal hereditary motor neuropathy using patient-derived iPSCs","volume":"13","author":"Perez-Siles","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C28","doi-asserted-by":"publisher","first-page":"dmm040840","DOI":"10.1242\/dmm.040840","article-title":"In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy","volume":"13","author":"Stay","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C29","doi-asserted-by":"publisher","first-page":"dmm032201","DOI":"10.1242\/dmm.032201","article-title":"A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR\/Cas9","volume":"11","author":"Sui","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C30","doi-asserted-by":"publisher","first-page":"dmm 043562","DOI":"10.1242\/dmm.043562","article-title":"Mouse models for muscular dystrophies: an overview","volume":"13","author":"van Putten","year":"2020","journal-title":"Dis"},{"key":"2024061302412818000_DMM044370C31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/d41573-019-00199-1","article-title":"A decade of optimizing drug development for rare neuromuscular disorders through TACT","volume":"19","author":"Wagner","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"2024061302412818000_DMM044370C32","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.035774","article-title":"Tracking progress: an update on animal models for Duchenne muscular dystrophy","volume":"11","author":"Wells","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C33","doi-asserted-by":"publisher","first-page":"dmm 042903","DOI":"10.1242\/dmm.042903","article-title":"Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)","volume":"13","author":"Willmann","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"2024061302412818000_DMM044370C34","doi-asserted-by":"publisher","first-page":"dmm040659","DOI":"10.1242\/dmm.040659","article-title":"A comparison of the bone and growth phenotype of mdx, mdx:Cmah\u2212\/\u2212 and mdx:Utrn+\/\u2212 murine models with the C57BL\/10 wild-type mouse","volume":"13","author":"Wood","year":"2020","journal-title":"Dis. Model. Mech."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.044370\/3484938\/dmm044370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.044370\/3484938\/dmm044370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T02:41:33Z","timestamp":1718246493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/13\/2\/dmm044370\/225292\/Moving-neuromuscular-disorders-research-forward"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.044370","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"article-number":"dmm044370"}}